1-hour venous plasma glucose and incident prediabetes and diabetes in Asian Indians

Diabetes Technology and Therapeutics

Volumn 15, Issue 6, 2013, Pages 497-502

  Priya, Miranda ^a   Anjana, Ranjit Mohan ^a   Chiwanga, Faraja S ^b   Gokulakrishnan, Kuppan ^a   Deepa, Mohan ^a   Mohan, Viswanathan ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b MUHIMBILI NATIONAL HOSPITAL   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INDIAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONE HOUR PLASMA GLUCOSE; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALUE; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FASTING; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INDIA; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; ROC CURVE; TIME FACTORS;

EID: 84878570473     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0025     Document Type: Article

References (46)

1. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus (Committee Report). Diabetes Care 2003;11:3160-3167.
2. Alberti KGMM, Zimmet PZ: Definition diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabet Med 1998;15:539-553. (Pubitemid 28319935)
3. World Health Organization: Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/ IDF Consultation. 2006. http://whqlibdoc.who.int/ publications/2006/9241594934-eng.pdf (accessed February 25, 2013).
4. UnwinN, Shaw J, Zimmet P, AlbertiKGMM: Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabetes Med 2002;19:708-723. (Pubitemid 35013848)
5. Abdul-Ghani MA, Tamam Abdul-Ghani T, Ali N, DeFronzo RA: One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk of future type 2 diabetes. Diabetes Care 2008;31:1650-1655.
6. Succurro E, Arturi F, Lugara M, Grembiale G, Fiorentino TV, Caruso V, Andreozzi F, Sciacqua A, Hribal ML, Perticone F, Sesti G: One hour post load plasma glucose levels are associated with kidneys dysfunction. Clin J Am Soc Nephrol 2010;5:1922-1927.
7. Barr EL, Boyko EJ, Zimmet PZ, Wolfe R, Tonkin AM, Shaw JE: Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Diabetologia 2009;52:415-424.
8. Joshi R: Metabolic syndrome - emerging clusters of the Indian phenotype. J Assoc Physicians India 2003;51:445-446.
9. Deepa R, Sandeep S, Mohan V: Abdominal obesity, visceral fat and type 2 diabetes - ''Asian Indian phenotype. In: Mohan V, Rao GHR, eds. Type 2 Diabetes in South Asians: Epidemiology, Risk Factors and Prevention. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd., 2006:138-152.
10. Mohan V, Deepa M, Deepa R, Shanthirani CS, Farooq S, Ganesan A, Datta M: Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India - the Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia 2006;49:1175-1178.
11. Ramachandran A., Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V; Indian Diabetes Prevention Programme (IDPP): The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49:289-297. (Pubitemid 43185397)
12. Joshi SR, Das AK, Vijay VJ, Mohan V: Challenges in diabetes care in India: sheer numbers, lack of awareness and inadequate control. J Assoc Physicians India 2008;56:443-450.
13. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, 1999.
14. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B; American Diabetes Association: Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007;30:753-759. (Pubitemid 46354366)
15. American Diabetes Association: Standards of medical care in diabetes - 2012. Diabetes Care 2012;35(Suppl 1):S11-S63.
16. American Diabetes Association: Standards of medical care in diabetes - 2013. Diabetes Care 2013;36(Suppl 1):S11-S66.
17. Kumar R, Indrayan A: Receiver operating characteristic (ROC) curve for medical researchers. Indian Pediatr 2011;48:277-287.
18. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36. (Pubitemid 12142173)
19. Stern MP, Williams K, Haffner SM: Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 2002;136:575-581. (Pubitemid 34407041)
20. Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RB Sr: Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 2007;167:1068-1074. (Pubitemid 46835795)
21. Mann DM, Bertoni AG, Shimbo D, Carnethon MR, Chen H, Jenny NS, Muntner P: Comparative validity of 3 diabetes mellitus risk prediction scoring models in a multiethnic US cohort: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 2010;171: 980-988.
22. Manco M, Panunzi S, Macfarlane DP, Golay A, Melander O, Konrad T, Petrie JR, Mingrone G; the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) Consortium: One hour plasma glucose identifies insulin resistance and b-cell dysfunction in individuals with normal glucose tolerance. Diabetes Care 2010;33:2090-2097.
23. Bae JC, Rhee EJ, Lee WY, Park SE, Park CY, Oh KW, Park SW, Kim SW: Optimal range of HbA1c for the prediction of future diabetes: a 4-year longitudinal study. Diabetes Res Clin Pract 2011;93:255-259.
24. Saudek CD, HermanWH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB: A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008;93:2447-2453. (Pubitemid 352008502)
25. Sacks DB: A1C versus glucose testing: a comparison. Diabetes Care 2011;34:518-523.
26. Bonora E, Tuomilehto J: The pros and cons of diagnosing diabetes with A1C. Diabetes Care 2011(Suppl 2):S184-S190.
27. Sacks DB; ADA/EASD/IDF Working Group of the HbA1c Assay: Global harmonization of hemglobin A1c. Clin Chem 2005;51:681-683.
28. American Diabetes Association; European Association for the Study of Diabetes; International Federation of Clinical Chemistry and Laboratory Medicine; International Diabetes Federation: Consensus statement on the worldwide standardisation of the HbA1c measurement. Diabetologia 2007;50:2042e3.
29. National Glycohemoglobin Standardization Program. www.ngsp.org/index.asp (accessed March 15, 2013).
30. Consensus Committee Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 2007;30:2399-2400.
31. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose (ADAG) Study Group: Translating the hemoglobin A1c assay into estimated average glucose values. Diabetes Care 2008;31:1473-1478.
32. International Expert Committee: International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334.
33. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl 1):S62-S69.
34. Mostafa SA, Davies MJ, Srinivasan BT, Carey ME, Webb D, Khunti K: Should glycated haemoglobin (HbA1c) be used to detect people with type 2 diabetes mellitus and impaired glucose regulation? Postgrad Med J 2010;86:656-662.
35. Unnikrishnan R, Anjana RM, Jayashri R, Mohan V: Unexpectedly low HbA1c levels in two diabetes patients following dapsone use. Indian J Endocrinol Metab 2012;16:658-659.
36. Unnikrishnan R, Anjana RM, Mohan V: Drugs affecting HbA1c levels. Indian J Endocr Metab 2012;16:528-531.
37. Diabetes Prevention Program Research Group: The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/ DPPOS. Diabetes Care 2012;35:723-730.
38. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403. (Pubitemid 34437694)
39. Janghorbani M, Amini M: Comparison of fasting glucose with post-load glucose values and glycated hemoglobin for prediction of type 2 diabetes: the Isfahan Diabetes Prevention Study. Rev Diabet Stud 2009;6:117-123.
40. Viswanathan V, Clementina M, Nair MB, Satyavani K: Risk of future diabetes is as high with abnormal intermediate post glucose response as with impaired glucose tolerance. J Assoc Physicians India 2007;55:833-837.
41. Viswanathan V, Kumpatla S, Michael C, Tilak P: Prevalence of metabolic syndrome among Asian Indian subjects with elevated intermediate glucose response during OGTT. Diabetes Res Clin Pract 2009;83:e17-e18.
42. Joshi SR, Karne R: Pre-diabetes, dysglycaemia and early glucose intolerance and vascular health. J Assoc Physicians India 2007;55:829-831.
43. Unnikrishnan R, Anjana RM, Mohan V: Importance of controlling diabetes early - the concept of metabolic memory, legacy effect and the case for early insulinisation. J Assoc Physicians India 2011;59(Suppl):8-12.
44. Mortaz S, Wessman C, Duncan R, Gray R, Badawi A: Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation. Clinicoecon Outcomes Res 2012;4: 91-97.
45. Cefalu WT: Steps toward the meaningful translation of prevention strategies for type 2 diabetes. Diabetes Care 2012; 35:663-665.
46. Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, Bhansali A, Joshi SR, Joshi PP, Yajnik CS, Dhandhania VK, Nath LM, Das AK, Rao PV, Madhu SV, Shukla DK, Kaur T, Priya M, Nirmal E, Parvathi SJ, Subhashini S, Subashini R, Ali MK, Mohan V; ICMR-INDIAB Collaborative Study Group: Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia 2011;54:3022-3027.